Marce S, Xicoy B, Garcia O, Cabezon M, Estrada N, Velez P, Boque C, Sagues M, Angona A, Teruel-Montoya R, Ferrer-Marin F, Amat P, Hernandez-Boluda JC, Ibarra MM, Anguita E, Cortes M, Fernandez-Ruiz A, Fontanals S, Zamora L, On Behalf Of The Grupo Espanol de Leucemia Mieloide Cronica Gelmc. Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib. J Clin Med. 2021 Jul 16;10(14):3146. doi: 10.3390/jcm10143146. PubMed PMID: 34300312; PubMed Central PMCID: PMC8307111.
AÑO: 2021; IF: 4.964